Search Results - D. A. Dibrov

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    ACCP-negative rheumatoid arthritis – clinical and immunological features

    ACCP-negative rheumatoid arthritis – clinical and immunological features by D. A. Dibrov

    Published 2022-07-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    New laboratory biomarkers of rheumatoid arthritis

    New laboratory biomarkers of rheumatoid arthritis by D. A. Dibrov

    Published 2021-05-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Rheumatoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the disease

    Rheumatoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the disease by E. L. Nasonov, A. S. Avdeeva, D. A. Dibrov

    Published 2023-06-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Fibrosing arthropathy in juvenile scleroderma

    Fibrosing arthropathy in juvenile scleroderma by D. A. Dibrov, M. N. Starovoitova, O. V. Desinova

    Published 2021-04-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Relationship of cytokine level dynamics with longterm results of early rheumatoid arthritis therapy

    Relationship of cytokine level dynamics with longterm results of early rheumatoid arthritis therapy by V. V. Rybakova, A. S. Avdeeva, D. A. Dibrov, Е. L. Nasonov

    Published 2022-03-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    The impact of T2T therapy on the treatment of the patients with the early rheumatoid arthritis (data from OREL registry)

    The impact of T2T therapy on the treatment of the patients with the early rheumatoid arthritis (data from OREL registry) by V. V. Rybakova, A. S. Avdeeva, D. A. Dibrov, E. L. Nasonov

    Published 2021-07-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Anti-carbamylated protein antibodies in ACCP-negative and ACCP-positive patients with rheumatoid arthritis

    Anti-carbamylated protein antibodies in ACCP-negative and ACCP-positive patients with rheumatoid arthritis by D. A. Dibrov, A. S. Avdeeva, M. E. Diatroptov, E. L. Nasonov

    Published 2024-01-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Biologically active additives in the 21st century: undenatured type II collagen as an example of good medical practice

    Biologically active additives in the 21st century: undenatured type II collagen as an example of good medical practice by I. S. Dydykina, D. A. Dibrov, K. S. Nurbaeva, P. S. Kovalenko, A. A. Kovalenko

    Published 2020-05-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Clinical features of ACPA-negative and ACPA-positive variants of rheumatoid arthritis

    Clinical features of ACPA-negative and ACPA-positive variants of rheumatoid arthritis by D. A. Dibrov, A. S. Avdeeva, V. V. Rybakova, N. V. Demidova, E. L. Nasonov

    Published 2023-04-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Combination of ankylosing spondylitis with combined autoinflammatory skin lesions (clinical observation and literature review)

    Combination of ankylosing spondylitis with combined autoinflammatory skin lesions (clinical observation and literature review) by D. A. Dibrov, T. V. Korotaeva, S. O. Krasnenko, M. M. Urumova, L. S. Kruglova, A. M. Lila

    Published 2021-08-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Combination of ankylosing spondylitis with combined autoinflammatory skin lesions. Clinical case and review

    Combination of ankylosing spondylitis with combined autoinflammatory skin lesions. Clinical case and review by D. A. Dibrov, T. V. Korotaeva, S. O. Krasnenko, M. M. Urumova, L. S. Kruglova, A. M. Lila

    Published 2020-12-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Depletion-restitution therapy for autoimmune rheumatic diseases. Part 1. Fundamental prerequisites and efficacy of modern treatment technologies: anti-B-cell drugs and CAR-T therapy

    Depletion-restitution therapy for autoimmune rheumatic diseases. Part 1. Fundamental prerequisites and efficacy of modern treatment technologies: anti-B-cell drugs and CAR-T therap... by A. M. Lila, A. L. Maslyanskiy, D. A. Dibrov, A. V. Torgashina, E. G. Zotkin, M. Yu. Samsonov

    Published 2025-04-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    Depletion-restitution therapy of autoimmune rheumatic diseases. Part 2. Perspectives on bispecific antibodies

    Depletion-restitution therapy of autoimmune rheumatic diseases. Part 2. Perspectives on bispecific antibodies by A. L. Maslyanskiy, D. A. Dibrov, A. M. Lila, A. V. Torgashina, E. G. Zotkin, M. Yu. Samsonov, G. A. Togizbayev

    Published 2025-06-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: